FDA.reportPublic FDA data

varicella-zoster immune globulin 125 UNT per 1.2 ML Injection

RxCUI
252016
RxNorm name
varicella-zoster immune globulin 125 UNT per 1.2 ML Injection
Display name
varicella-zoster immune globulin 125 UNT per 1.2 ML Injection
Full name
varicella-zoster immune globulin 125 UNT per 1.2 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125430VarizigVaricella Zoster Immune Globulin (Human)351(a)Disc2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f367f996-aafa-4b8b-8cb4-63a009cd2015varicella zoster immune globulin (human) 125 UNT in 1.2 ML Injection [PSN] · 1.2 ML varicella-zoster immune globulin 104 UNT/ML Injection [SCD] · varicella-zoster immune globulin 125 UNT per 1.2 ML Injection [SY]35These highlights do not include all the information needed to use VARIZIG ® safely and effectively. See full prescribing information for VARIZIG. VARIZIG ® [Varicella Zoster Immune Globulin (Human)] for intramuscular administration only. Sterile Solution for Injection Initial U.S. Approval: 201220260210